Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
149.88
Dollar change
+0.18
Percentage change
0.12
%
IndexDJIA, S&P 500 P/E21.59 EPS (ttm)6.94 Insider Own0.16% Shs Outstand2.41B Perf Week2.32%
Market Cap360.71B Forward P/E13.78 EPS next Y10.88 Insider Trans-1.74% Shs Float2.40B Perf Month2.13%
Income17.49B PEG4.52 EPS next Q2.71 Inst Own71.63% Short Float0.88% Perf Quarter0.73%
Sales89.66B P/S4.02 EPS this Y6.44% Inst Trans-0.39% Short Ratio2.82 Perf Half Y-7.41%
Book/sh29.09 P/B5.15 EPS next Y3.02% ROA9.15% Short Interest21.17M Perf Year-5.19%
Cash/sh10.89 P/C13.76 EPS next 5Y4.78% ROE23.91% 52W Range143.13 - 175.97 Perf YTD-4.38%
Dividend Est.4.81 (3.21%) P/FCF19.29 EPS past 5Y-0.27% ROI18.39% 52W High-14.83% Beta0.52
Dividend TTM4.81 (3.21%) Quick Ratio0.94 Sales past 5Y1.31% Gross Margin68.49% 52W Low4.72% ATR (14)2.04
Dividend Ex-DateMay 20, 2024 Current Ratio1.17 EPS Y/Y TTM44.66% Oper. Margin25.66% RSI (14)60.43 Volatility1.40% 1.36%
Employees131900 Debt/Eq0.48 Sales Y/Y TTM-6.90% Profit Margin19.51% Recom2.14 Target Price171.77
Option/ShortYes / Yes LT Debt/Eq0.36 EPS Q/Q5231.80% Payout84.93% Rel Volume0.71 Prev Close149.70
Sales Surprise-0.08% EPS Surprise2.04% Sales Q/Q-13.55% EarningsJul 17 BMO Avg Volume7.52M Price149.88
SMA202.10% SMA501.22% SMA200-2.37% Trades Volume5,303,621 Change0.12%
Date Action Analyst Rating Change Price Target Change
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
May-30-23Resumed Citigroup Buy $185
Mar-29-23Initiated UBS Neutral $164
Mar-01-23Initiated Guggenheim Neutral $161
Nov-18-22Initiated Credit Suisse Neutral $170
Today 12:16PM
12:10PM
09:31AM
09:00AM
07:00AM
04:27AM Loading…
04:27AM
Jul-12-24 05:16PM
09:15AM
06:23AM
Jul-11-24 02:53PM
07:30AM
04:51AM
Jul-10-24 05:45PM
10:13AM
07:00AM
10:01AM Loading…
Jul-09-24 10:01AM
09:25AM
Jul-08-24 02:01PM
08:00AM
06:45AM
Jul-05-24 01:43PM
11:32AM
10:10AM
Jul-04-24 02:13PM
12:00PM
06:00AM
Jul-03-24 03:32PM
10:00AM
08:00AM
08:00AM
07:37AM Loading…
07:37AM
05:12AM
04:52AM
Jul-02-24 04:45PM
11:06AM
09:55AM
07:30AM
Jul-01-24 04:30PM
12:19PM
10:36AM
09:53AM
06:50AM
06:00AM
Jun-30-24 10:13AM
05:40AM
Jun-29-24 08:21AM
Jun-28-24 04:37PM
11:30AM
Jun-27-24 08:50PM
08:45PM
06:46PM
09:00AM
09:00AM
04:23AM
Jun-26-24 12:53PM
Jun-25-24 05:45PM
06:54AM
06:41AM
Jun-24-24 10:05AM
09:13AM
08:34AM
08:13AM
08:00AM
Jun-22-24 06:03AM
04:45AM
Jun-21-24 12:14PM
08:49AM
07:30AM
06:53AM
02:39AM
Jun-20-24 05:26PM
04:30PM
08:39AM
08:00AM
07:30AM
05:15AM
Jun-19-24 10:45PM
01:53PM
05:21AM
Jun-18-24 05:45PM
03:24PM
06:13AM
Jun-17-24 09:00AM
08:00AM
06:32AM
Jun-15-24 06:42AM
06:00AM
03:30AM
Jun-14-24 11:45AM
08:00AM
05:00AM
Jun-13-24 09:00AM
Jun-12-24 02:26PM
11:17AM
07:30AM
06:10AM
Jun-11-24 05:45PM
03:16PM
02:49PM
02:09PM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Broadhurst VanessaEVP, Global Corp AffairsJul 08 '24Option Exercise0.009,809024,852Jul 09 05:48 PM
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '24Option Exercise0.0022,255022,561May 03 04:31 PM
Broadhurst VanessaEVP, Global Corp AffairsMar 13 '24Sale162.168,8911,441,76515,043Mar 13 04:36 PM
JOHNSON & JOHNSON10% OwnerFeb 29 '24Option Exercise0.723,8552,7924,103,430Mar 06 03:42 PM
JOHNSON & JOHNSON10% OwnerFeb 16 '24Sale25.813,72596,1424,099,575Mar 06 03:42 PM
Decker Robert JVP Corporate ControllerFeb 13 '24Option Exercise0.00313019,059Feb 15 04:53 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '24Option Exercise0.00408024,143Feb 15 04:53 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '24Option Exercise0.0065108,576Feb 15 04:53 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '24Option Exercise0.003,4700364,809Feb 15 04:53 PM
Hait WilliamSee RemarksFeb 13 '24Option Exercise0.00834039,074Feb 15 04:53 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 13 '24Option Exercise0.009250112,550Feb 15 04:53 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '24Option Exercise0.00499013,290Feb 15 04:53 PM
Swanson James D.EVP, CIOFeb 13 '24Option Exercise0.00447014,765Feb 15 04:53 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '24Option Exercise0.001,3020155,517Feb 15 04:53 PM
Wolk Joseph JExec VP, CFOFeb 13 '24Option Exercise0.001,780069,663Feb 15 04:53 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '24Option Exercise0.00651082,599Feb 15 04:53 PM
Decker Robert JVP Corporate ControllerFeb 12 '24Option Exercise0.001,912019,269Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 12 '24Option Exercise0.0036,6180377,239Feb 14 06:36 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 12 '24Option Exercise0.0026,2020167,618Feb 14 06:36 PM
Forminard ElizabethExecutive VP, General CounselFeb 12 '24Option Exercise0.002,85908,959Feb 14 06:36 PM
Wolk Joseph JExec VP, CFOFeb 12 '24Option Exercise0.0025,835078,699Feb 14 06:36 PM
Hait WilliamSee RemarksFeb 12 '24Option Exercise0.008,932042,316Feb 14 06:36 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 12 '24Option Exercise0.004,701025,081Feb 14 06:36 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 12 '24Option Exercise0.0013,813089,014Feb 14 06:36 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 12 '24Option Exercise0.005,736015,678Feb 14 06:36 PM
Swanson James D.EVP, CIOFeb 12 '24Option Exercise0.005,456016,013Feb 14 06:36 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12 '24Option Exercise0.0014,9600118,644Feb 14 06:36 PM
Duato JoaquinCEO and Chairman of the BoardFeb 09 '24Option Exercise90.44130,96911,844,836439,283Feb 13 05:18 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Option Exercise90.4459,3975,371,865200,813Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 09 '24Sale156.2759,3979,281,969141,416Feb 12 07:25 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08 '24Option Exercise0.003,7390143,329Feb 12 07:25 PM
Decker Robert JVP Corporate ControllerFeb 08 '24Option Exercise0.00655017,572Feb 12 07:24 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 08 '24Option Exercise0.001,880021,083Feb 12 07:24 PM
Hait WilliamSee RemarksFeb 08 '24Option Exercise0.003,059034,497Feb 12 07:24 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08 '24Option Exercise0.002,1350104,465Feb 12 07:24 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 08 '24Option Exercise0.001,964010,943Feb 12 07:24 PM
Swanson James D.See RemarksFeb 08 '24Option Exercise0.001,868011,111Feb 12 07:24 PM
Forminard ElizabethExecutive VP, General CounselFeb 08 '24Option Exercise0.0097906,463Feb 12 07:24 PM
Wolk Joseph JExec VP, CFOFeb 08 '24Option Exercise0.003,686053,911Feb 12 07:25 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 08 '24Option Exercise0.001,971067,905Feb 12 07:25 PM
Duato JoaquinCEO and Chairman of the BoardFeb 08 '24Option Exercise0.005,2250310,583Feb 12 07:25 PM
Hait WilliamSee RemarksJul 26 '23Option Exercise90.4414,6981,329,287102,445Jul 27 05:52 PM
Hait WilliamSee RemarksJul 26 '23Sale172.0014,6982,528,05687,747Jul 27 05:52 PM
Fasolo PeterExec VP, Chief HR OfficerJul 25 '23Sale170.3220,0003,406,498102,696Jul 27 05:52 PM